The dosage information for drugs used in HIV treatment, malaria, cancer care, pain management and transplantation is largely ...
Medical genetics is the discipline that examines how variation in our DNA underlies health and disease. It spans rare, highly penetrant single-gene disorders and the more complex, multifactorial ...
While remarkable and life-saving innovations in human genetics continue to make headlines worldwide, genetics professionals are now raising increasingly urgent warnings about how these advances are ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...
The program will help make genetic counselors available to any provider across different medical specialties in Tennessee and ...
The American College of Medical Genetics and Genomics has just published its highly anticipated Evidence-Based Clinical Guideline (EBG): “Phenylalanine Hydroxylase (PAH) Deficiency Diagnosis and ...
The Division of Pediatric Medical Genetics evaluates, diagnoses and cares for children with known and suspected genetic disorders. They primarily treat patients at SSM Health Cardinal Glennon Children ...
BETHESDA, MD – January 9, 2026 | The American College of Medial Genetics and Genomics (ACMG) announced today that press registration is now open for the 2026 ACMG Annual Clinical Genetics Meeting, ...
Researchers from Children's Hospital of Philadelphia (CHOP) have fine-tuned large language models (LLMs) to analyze clinical data, aiding medical teams in determining which available genetic tests are ...
Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
In the Department of Genetics, doctors are using genetic and genomic testing to pinpoint the exact cause of a patient’s condition—even when symptoms mimic more than one disorder. This clarity is ...
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 9.2% in the morning session after the company expanded the availability of its Precise MRD test for breast, colorectal, and renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results